Every open market buy and sale of Arcus Biosciences, Inc. stock by its officers, directors and 10% owners over the last two years, straight from SEC Form 4 filings. Insiders are only selling over the last 12 months: $0 bought and $9.5M sold.
Buying and selling by month
open market, last 12 monthsGet an alert when RCUS insiders trade
We read every Form 4 the moment the SEC posts it and tell you when an RCUS officer, director or 10% owner buys on the open market, or sells $250K or more outside a pre-arranged plan, by email or on your phone.
Insider alerts are part of AI Pro. Start with a free account, then add AI Pro when you want the alerts.
Every RCUS insider trade
2 years · newest first| Insider | Type | Price | Held after | Filed | |||
|---|---|---|---|---|---|---|---|
| Aug 21, 2026 | Alexander AzoyChief Accounting Officer | Sale plan | 2,827 | $30.00 | $85K | 39,581 | Aug 24Form 4 |
| Jul 10, 2026 | Juan C. JaenPresident | Sale plan | 68,569 | $29.63 | $2M | 822,240 | Jul 13Form 4 |
| Jun 24, 2026 | Juan C. JaenPresident | Sale plan | 31,431 | $27.92 | $878K | 890,809 | Jun 24Form 4 |
| Jun 1, 2026 | Alexander AzoyChief Accounting Officer | Sale plan | 2,562 | $25.77 | $66K | 39,581 | Jun 1Form 4 |
| May 11, 2026 | II Robert C. GoeltzCFO | Sale plan | 7,763 | $25.63 | $199K | 84,161 | May 12Form 4 |
| Jan 5, 2026 | Juan C. JaenPresident | Sale plan | 31,823 | $21.41 | $681K | 922,240 | Jan 7Form 4 |
| Dec 31, 2025 | II Robert C. GoeltzCFO | Sale plan | 6,552 | $23.38 | $153K | 67,924 | Jan 2Form 4 |
| Dec 18, 2025 | Alexander AzoyChief Accounting Officer | Sale plan | 8,832 | $22.13 | $195K | 18,531 | Dec 18Form 4 |
| Dec 17, 2025 | Terry J RosenCEO | Sale plan | 54,691 | $22.01 | $1.2M | 2,194,809 | Dec 18Form 4 |
| Dec 17, 2025 | Juan C. JaenPresident | Sale plan | 21,208 | $22.01 | $467K | 346,012 | Dec 18Form 4 |
| Dec 17, 2025 | II Robert C. GoeltzCFO | Sale plan | 12,662 | $22.01 | $279K | 74,476 | Dec 18Form 4 |
| Dec 17, 2025 | Jennifer JarrettCOO | Sale plan | 21,208 | $22.01 | $467K | 193,024 | Dec 18Form 4 |
| Dec 17, 2025 | Carolyn C. TangGeneral Counsel | Sale plan | 14,468 | $22.01 | $318K | 124,734 | Dec 18Form 4 |
| Dec 17, 2025 | Richard MarkusChief Medical Officer | Sale plan | 9,546 | $22.01 | $210K | 65,647 | Dec 18Form 4 |
| Dec 4, 2025 | Juan C. JaenPresident | Sale plan | 82,997 | $24.71 | $2.1M | 954,063 | Dec 5Form 4 |
RCUS insider trading FAQ
Are RCUS insiders buying or selling?
Insiders are only selling over the last 12 months. 0 insiders bought $0 of RCUS on the open market in 0 trades, and 7 sold $9.5M in 17 trades, 100% of that under pre-arranged trading plans.
When did an RCUS insider last buy shares?
Terry J Rosen (CEO) bought 19,800 shares for $202K on Feb 27, 2025, reported on Feb 27, 2025.
When did an RCUS insider last sell shares?
Alexander Azoy (Chief Accounting Officer) sold 2,827 shares for $85K on Aug 21, 2026, under a pre-arranged trading plan.
What is a Form 4?
Company officers, directors and owners of more than 10% of the shares must report trades in the company's stock to the SEC on Form 4 within two business days. This page shows open market buys and sales only. Option exercises, stock awards, gifts and shares withheld for taxes are left out, since they are not decisions to buy or sell.
Why do insider sales matter less than buys?
Insiders sell for many reasons, such as taxes, diversification or a home purchase, and many sales are scheduled months ahead under a 10b5-1 trading plan. They buy on the open market mostly when they expect the shares to rise, which is why buying, and especially several insiders buying together, gets more attention.
For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Trades come from SEC Form 4 filings as reported by the insiders. Insiders have two business days to report, so a trade can be a few days old when it appears. See all insider cluster buys.
From SEC Form 4 filings · Not investment advice
